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Draft Genome Sequence of Amycolatopsis lurida NRRL 2430, Producer
of the Glycopeptide Family Antibiotic Ristocetin
Min Jung Kwun, Hee-Jeon Hong
Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom
We report here the first draft genome sequence for Amycolatopsis luridaNRRL 2430, the producer of the glycopeptide antibiotic
ristocetin. The 9-Mbp genome is predicted to harbor 8,143 genes, including those belonging to the ristocetin biosynthesis cluster
and 31 additional predicted secondary metabolite gene clusters.
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The glycopeptide family antibiotic ristocetin was originally used totreat Gram-positive pathogenic infections in humans, particularly
staphylococcal infections.Thisusewas soondiscontinued,however,due
to toxic side effects related to its ability to cause thrombocytopenia and
platelet agglutination (1).Today, ristocetin is applied to the in vitrodiag-
nosis of conditions, suchas vonWillebranddisease andBernard-Soulier
syndrome;bloodfrompatientswiththesyndromesfail toexhibitaplate-
let agglutination response to ristocetin due to an absence of vonWille-
brand factor or its receptor (2).Amycolatopsis lurida is known to be the
only producer of commercial ristocetin so far, but neither the whole-
genomesequenceinformationnorthesequenceofitsristocetinsynthetic
gene cluster have been available. The sequence of the ristocetin biosyn-
thesis gene cluster from A. luridawas recently published (GenBank ac-
cessionno.KJ364518) (3).
TheA. luridaNRRL2430genomewassequencedto67-foldcoverage
using an IlluminaMiSeq instrument, and itwas assembledusing theGS
de novo Assembler (Newbler software version 2.9). A total of 1,993,479
readswereassembledinto101contigstoproduceadraftgenomewithan
estimated size of 8,987,656 bp. The average contig size is 73,852 bp, and
the largest single contig contains 424,186 bp. Annotation of the genome
was performed using theNCBI Prokaryotic GenomeAnnotation Pipe-
line (4)withGeneMarkS (5). This annotation predicted 8,143 coding
sequences (CDSs)with 109pseudogenes, 54 tRNAs, two5S rRNAs, one
23S rRNA, andanoverallGCcontentof 68.71%.Theassembleddraft
genome sequence does not include any identifiable sequence for 16S
rRNA, so we separately sequenced 16S rRNA in A. luridaNRRL 2430.
Amongseveral16SrRNAsofdifferenttypestrainsofA.luridaavailablein
the GenBank database, the 16S rRNA sequence from A. lurida NRRL
2430 perfectly matched one under the accession no. AJ577997 (6). Ac-
cordingtothephylogeneticanalysisof the16SrRNAsequences,A. lurida
NRRL2430 is taxonomicallymost closely related to the strainAmycola-
topsis orientalisHCCB10007, with 99% 16S rRNA identity. Analysis for
secondary metabolite gene clusters using antiSMASH (7) identified 32
predicted clusters in the A. lurida NRRL 2430 genome, including the
ristocetin synthetic gene cluster and clusters putatively responsible for
producing terpenes,bacteriocins, typeI, II, andIIIpolyketideantibiotics,
nonribosomalpeptidesynthetase(NRPS)compounds,ectoine,andsev-
eral other unknown compounds
The genome information for A. lurida NRRL 2430 will help with
understanding the mechanisms involved in the regulation of ristocetin
biosynthesis, aswell as assist the search for bothnewbioactivemicrobial
metabolites andnovel secondarymetabolite-related enzyme activities.
Nucleotide sequence accession numbers. The draft genome se-
quenceofA. luridaNRRL2430hasbeendeposited in theDDBJ/EMBL/
GenBank database under the accession no. JFBM00000000. The ver-
sion described in this paper is the first version, JFBM01000000.
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